Duin Jan J, Baltussen Joosje C, Albalak Gali, van Dam van Isselt Eléonore F, Portielje Johanneke E A, Mooijaart Simon P, Soto-Perez-de-Celis Enrique, van den Bos Frederiek
Department of Internal Medicine, Section of Geriatrics and Gerontology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
LUMC Center for Medicine for Older People, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Oncologist. 2025 Aug 4;30(8). doi: 10.1093/oncolo/oyae319.
Despite the increasing integration of wearable technology in oncology, its application in the care of older adults, representing most patients with cancer, is poorly defined.
This systematic review aimed to summarize the current use of wearables in studies in older adults with cancer.
This systematic review was conducted following the PRISMA guidelines. A systematic search was conducted in PubMed, Embase, Emcare, Web of Science, and Cochrane Library on May 1, 2024. Studies involving wearable devices and patients aged ≥60 years diagnosed with cancer were included. Outcomes reported were study characteristics, wearable outcomes, feasibility and adherence. The mixed method appraisal tool was used to assess the quality of included studies.
A total of 31 publications were included, comprising 1298 older patients. Of these, 12 were pilot/feasibility studies, 12 were observational studies, 6 were randomized controlled trials, and 1 was a cross-sectional study. Most studies used wearable data to measure recovery (19 studies, 61%). Physical activity was the most studied wearable outcome (27 studies, 87%). Adherence to the wearable device was documented in 11 of the 31 studies (35%), with adherence ranging from 74% to 100%.
Our systematic review found wearables were mostly used to measure physical activity, with the most common primary aim of measuring recovery. Most studies reported high adherence, although definitions of adherence were diverse. Our results highlight the need for more and larger studies on wearable technology in older cancer patients, the use of standardized reporting frameworks, and increased participation in research in low- and middle-income countries.
尽管可穿戴技术在肿瘤学中的应用日益广泛，但其在老年癌症患者护理中的应用仍不明确，而老年患者占癌症患者的大多数。
本系统评价旨在总结可穿戴设备在老年癌症患者研究中的当前应用情况。
本系统评价按照PRISMA指南进行。于2024年5月1日在PubMed、Embase、Emcare、Web of Science和Cochrane图书馆进行了系统检索。纳入涉及可穿戴设备且年龄≥60岁的癌症确诊患者的研究。报告的结果包括研究特征、可穿戴设备的结果、可行性和依从性。采用混合方法评估工具评估纳入研究的质量。
共纳入31篇文献，涉及1298名老年患者。其中，12篇为试点/可行性研究，12篇为观察性研究，6篇为随机对照试验，1篇为横断面研究。大多数研究使用可穿戴设备数据来衡量恢复情况（19项研究，61%）。身体活动是研究最多的可穿戴设备结果（共27项研究，87%）。31项研究中有11项（35%）记录了对可穿戴设备的依从性，依从率在74%至100%之间。
我们的系统评价发现，可穿戴设备主要用于测量身体活动，最常见的主要目的是测量恢复情况。大多数研究报告了较高的依从性，尽管依从性的定义各不相同。我们的结果强调，需要对老年癌症患者的可穿戴技术进行更多、更大规模的研究，采用标准化报告框架，并增加低收入和中等收入国家的研究参与度。
Zotero 插件